
High-Throughput Pharmacologic Activity Profiling of Antibodies
Profile every Fc receptor, serum binder, and DEL hit on one device
- lino Biotech AG
- May 2026
Drug discovery demands high-throughput binding measurements across diverse compound classes, protein targets, and biological matrices. Yet most label-free biosensors require purified samples and measure one compound at a time. The MACS Matchmaker, based on focal molography, breaks both limits: up to 64 simultaneous interactions per chip, label-free, in undiluted plasma, serum, or cell lysate.
Application 1: 8-plex Fc receptor profiling panel
FcγRI, FcγRIIa, FcγRIIb, FcγRIIIa, FcγRIIIb, FcεRI, FcεRII, and the neonatal Fc receptor (FcRn) co-immobilized via DNA-directed immobilization (DDI) on a single chip. Antibody candidates injected as analytes give a full effector function profile from a single experiment, directly in development buffer. The profile discriminates IgG subclasses (IgG1, IgG2, IgG4) and engineered Fc variants (LALA, GASDALIE, YTE).
Application 2: serum protein binding
Three FDA-approved anti-CD20 antibodies (rituximab, obinutuzumab, ofatumumab) profiled in human serum within a 1-hour single-cycle kinetic run. Apparent dissociation constants (KD) cluster around 1 µM in full human serum. A partially humanized reference antibody shows a distinctly different serum-interaction profile (~4× higher KD). The MACS Matchmaker delivers the answer in plasma, in parallel, in one hour, a question SPR cannot answer.
Application 3: on-DNA DEL hit validation
Conventional DNA-encoded library (DEL) hit validation requires off-DNA synthesis, the hit made again without its DNA tag, before biophysical testing. That route has a 70 to 90 percent false-positive rate and takes weeks to months. Focal molography enables direct on-DNA affinity measurement of intact DEL hits via DDI. It ranks kon, koff, and KD per compound with the same library prep used for screening. Lower false positives, hours instead of weeks, and LC-MS identifies which binds.
Presented at PEGS Boston 2026, Booth 615 (Poster A073). Authors: Lukas Heuberger, Alexander Geiger, Andreas Frutiger, Simona Notova, Volker Gatterdam, lino Biotech AG (a Miltenyi Biotec Company).
More from our resource library you may like
Oct 2026
High-throughput thermodynamic fingerprinting of protein–ligand interactions by DNA-directed focal molography
Oehninger, Notova, Frutiger
Oehninger, J., Notova, S., & Frutiger, A. (2026). PLOS One, 21(10), e0354008. https://doi.org/10.1371/journal.pone.0354008
Download after a short form
Oct 2026
Same target, different stickiness: polyreactivity of therapeutic antibodies
lino Biotech AG
Six clinical antibodies, including two same-target pairs, ranked by polyreactivity against an eight-ligand panel on one focal molography chip. Briakinumab scored 69-fold above ...
Download after a short form
Oct 2026
One on-DNA ligand against many targets: selectivity profiling for DEL hit validation
lino Biotech AG
On-DNA oncoFAP profiled against human, mouse and canine FAP and five unrelated proteins on one focal molography chip layout. Full kinetics on every species variant, flat responses ...
Download after a short form